NASDAQ: QNTM
Quantum Biopharma Ltd Stock Ownership - Who owns Quantum Biopharma?

Insider buying vs selling

Have Quantum Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when QNTM insiders and whales buy or sell their stock.

QNTM Shareholders

What type of owners hold Quantum Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ubs Group Ag1.32%45,883$773.13kInstitution
Advisorshares Investments LLC1.07%36,990$623.28kInstitution
Virtu Financial LLC0.48%16,706$281.50kInstitution
Lpl Financial LLC0.31%10,917$183.95kInstitution
Steward Partners Investment Advisory LLC0.09%3,100$52.24kInstitution
Jpmorgan Chase Co0.03%897$15.11kInstitution
Bnp Paribas Financial Markets0.02%700$11.80kInstitution
Tower Research Capital LLC Trc0.02%544$9.17kInstitution
Cetera Trust Company Na0.01%250$4.21kInstitution
Sbi Securities Co Ltd0.00%155$2.61kInstitution

1 of 2

QNTM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNTM3.36%0.00%
CPIX24.61%55.83%Net BuyingNet Buying
BGM1.83%0.00%
DRRX8.68%91.32%Net BuyingNet Buying
RMTI14.01%85.99%Net SellingNet Selling

Quantum Biopharma Stock Ownership FAQ

Who owns Quantum Biopharma?

Quantum Biopharma (NASDAQ: QNTM) is owned by 3.36% institutional shareholders, 0.00% Quantum Biopharma insiders, and 96.64% retail investors. Ubs Group Ag is the largest individual Quantum Biopharma shareholder, owning 45,883.00 shares representing 1.32% of the company. Ubs Group Ag's Quantum Biopharma shares are currently valued at $748.12k.

If you're new to stock investing, here's how to buy Quantum Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.